Verona Pharma Plc Adr (VRNA)

Verona Pharma Plc Adr Azioni (VRNA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	42.44% 27.20	19.09	16.31	9.965	22.20
Interest Income/Expense	154.57% 1.586	0.623	0.401	0.74	0.293
Operating Income/Loss	42.44% -27.20	-19.09	-16.31	-9.965	-22.20
Nonoperating Income/Loss	56.04% 2.158	4.909	1.668	1.468	5.629
Income/Loss From Continuing Operations Before Tax	76.52% -25.04	-14.19	-14.64	-8.497	-16.57
Income Tax Expense/Benefit	1,523% 0.754	-0.053	0.044	0.31	0.173
Income/Loss From Continuing Operations After Tax	82.52% -25.79	-14.13	-14.69	-8.807	-16.74
Net Income/Loss	82.52% -25.79	-14.13	-14.69	-8.807	-16.74
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23,861% 645.70	2.6948	638.24	634.47	621.45
Diluted Average Shares	23,861% 645.70	2.6948	638.24	634.47	621.45
Basic Earnings Per Share	33.33% -0.04	-0.03	-0.02	-0.01	-0.03
Diluted Earnings Per Share	33.33% -0.04	-0.03	-0.02	-0.01	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-